Diabetes and Vascular Disease Research · 2020 · 20 citations · 23 references
Life SciencesBiochemistryCell BiologyCell SignalingInflammationSignal TransductionPolysaccharide FunctionPolysaccharide PropertiesPolysaccharide StructureAdvanced Glycation End ProductsDiabetic ComplicationsGlycosaminoglycansPolysaccharide-protein InteractionsScavenger Receptor-mediated UptakeScavenger Receptors
Advanced glycation end-products, especially toxic advanced glycation end-products derived from glyceraldehyde (advanced glycation end-product-2) and glycolaldehyde (advanced glycation end-product-3), are biologically reactive compounds associated with diabetic complications. We previously demonstrated that toxic advanced glycation end-products were internalised into macrophage-like RAW264.7 cells through scavenger receptor-1 class A (CD204). Toxic advanced glycation end-product uptake was inhibited by fucoidan, a sulphated polysaccharide and antagonistic ligand for scavenger receptors, suggesting that sulphated polysaccharides are emerging candidates for treatment of advanced glycation end-product-related diseases. In this study, we compared the effects of six types of sulphated and non-sulphated polysaccharides on toxic advanced glycation end-product uptake in RAW264.7 cells. Fucoidan, carrageenan and dextran sulphate attenuated toxic advanced glycation end-product uptake. Fucoidan and carrageenan inhibited advanced glycation end-product-2-induced upregulation of SR-A, while advanced glycation end-product-3-induced upregulation of scavenger receptor-1 class A was only suppressed by fucoidan. Dextran sulphate did not affect scavenger receptor-1 class A levels in toxic advanced glycation end-product-treated cells. Chondroitin sulphate, heparin and hyaluronic acid failed to attenuate toxic advanced glycation end-product uptake. Heparin and hyaluronic acid had no effect on scavenger receptor-1 class A levels, while chondroitin sulphate inhibited advanced glycation end-product-3-induced upregulation of scavenger receptor-1 class A. Taken together, fucoidan and carrageenan, but not the other sulphated polysaccharides examined, had inhibitory activities on toxic advanced glycation end-product uptake and toxic advanced glycation end-product-induced upregulation of scavenger receptor-1 class A, possibly because of structural differences among sulphated polysaccharides.
23
Type I macrophage scavenger receptor contains α-helical and collagen-like coiled coils
Tatsuhiko Kodama, Mason W. Freeman, Lucia Rohrer et al. · Nature · 1990 · 1K citations
Heparin and Low-Molecular-Weight Heparin
Jack Hirsh, Robert Raschke · CHEST Journal · 2004 · 961 citations
Immunomodulation and antitumor activity of κ-carrageenan oligosaccharides
Huamao Yuan, Jie Song, Xin Li et al. · Cancer Letters · 2006 · 319 citations
Life Sciences, Immunology, Oncology +14